Drugs / ICV
last change May 2023 re-read 2 minutes ago

ICV

Vaccine

Developed for
COVID-19

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05330871 Comparator Apr → Jun 2022 COVID-19 Seventh Medical Center of PLA General Hospital Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ICV ICV, 1 dose 0.5ml” NCT05330871
Modality Vaccine “Inactivated COVID-19 VaccineNCT05330871
Route Intramuscular “0.5ml intramuscular inactivated vaccine ICV” NCT05330871